21. Qualitative Change in Migraine Prevention?. Issue 7 (23rd July 2018) Authors: Cady, Roger; Lipton, Richard B. Journal: Headache Issue: Volume 58:Issue 7(2018) Page Start: 1092 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis. (April 2015) Authors: Chabi, Almira; Zhang, Ying; Jackson, Saheeda; Cady, Roger; Lines, Christopher; Herring, W Joseph; Connor, Kathryn M; Michelson, David Journal: Cephalalgia Issue: Volume 35:Number 5(2015) Page Start: 379 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Redefining Expectations for Migraine Prevention: Highlights of a satellite symposium sponsored by Lundbeck Seattle BioPharmaceuticals, Inc. (AKA Alder BioPharmaceuticals) held at the 61st Annual American Headache Society meeting in Philadelphia, PA, USA. (2021) Authors: Cady, Roger; Gottschalk, Christopher; Pavlovic, Jelena Journal: Touch reviews in neurology Issue: Volume 17(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine. (September 2022) Authors: McAllister, Peter; Kudrow, David; Cady, Roger; Hirman, Joe; Ettrup, Anders Journal: Cephalalgia Issue: Volume 42:Number 10(2022) Page Start: 1005 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial. Issue 4 (April 2016) Authors: Sun, Hong; Dodick, David W; Silberstein, Stephen; Goadsby, Peter J; Reuter, Uwe; Ashina, Messoud; Saper, Joel; Cady, Roger; Chon, Yun; Dietrich, Julie; Lenz, Robert Journal: Lancet neurology Issue: Volume 15:Issue 4(2016:Apr.) Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Sublingual Feverfew/Ginger (LipiGesic M) Reanalysis of Data. Issue 2 (22nd February 2013) Authors: Cady, Roger; Serrano, Daniel; Lipton, Richard; Browning, Rebecca Journal: Headache Issue: Volume 53:Issue 2(2013) Page Start: 384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. SumaRT/Nap vs Naproxen Sodium in Treatment and Disease Modification of Migraine: A Pilot Study. Issue 1 (10th September 2013) Authors: Cady, Roger; O'Carroll, Phillip; Dexter, Kent; Freitag, Fred; Shade, Candace L. Journal: Headache Issue: Volume 54:Issue 1(2014) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Symptomatic Overlap and Therapeutic Opportunities in Primary Headache. (August 2015) Authors: Cady, Roger; Garas, Sandy Yacoub; Patel, Ketu; Peterson, Andrew; Wenzel, Richard Journal: Journal of pharmacy practice Issue: Volume 28:Number 4(2015:Aug.) Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. The pharmacokinetics and clinical efficacy of AVP-825: a potential advancement for acute treatment of migraine. (September 2015) Authors: Cady, Roger Journal: Expert opinion on pharmacotherapy Issue: Volume 16:Number 13(2015) Page Start: 2039 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Treatment of Chronic Migraine: A 3‐Month Comparator Study of Naproxen Sodium vs SumaRT/Nap. Issue 1 (10th September 2013) Authors: Cady, Roger; Nett, Robert; Dexter, Kent; Freitag, Fred; Beach, M.E.; Manley, Heather R. Journal: Headache Issue: Volume 54:Issue 1(2014) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗